Ticker Details
Arcturus Therapeutics Holdings Inc. Arcturus Therapeutics Ltd is a biotechnology company developing novel RNA medicines. The company develops novel RNA medicines in therapeutic areas including infectious disease, cystic fibrosis, nonalcoholic steatohepatitis (NASH) and rare liver diseases.
IPO Date:	May 22, 2013
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$233.64M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.95 | 3.80%
Avg Daily Range (30 D):	$0.20 | 2.71%
Avg Daily Range (90 D):	$0.17 | 2.40%

Institutional Daily Volume
Avg Daily Volume:	.41M
Avg Daily Volume (30 D):	.48M
Avg Daily Volume (90 D):	.47M

Trade Size
Avg Trade Size (Sh.):	65
Avg Trade Size (Sh.) (30 D):	63
Avg Trade Size (Sh.) (90 D):	66

Institutional Trades
Total Institutional Trades:	2,096
Avg Institutional Trade:	$2.04M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$1.23M
Avg Institutional Trade Volume:	.07M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.28M
Avg Closing Trade (30 D):	$1.12M
Avg Closing Trade (90 D):	$1.74M
Avg Closing Volume:	79.33K

News

Mar 23, 2026 @ 11:07 AM These Are the Only 3 Stocks That Cathie Wood Bough... Source: Rick Munarriz

Oct 23, 2025 @ 1:15 PM Cathie Wood Goes Shopping: 3 Stocks She Just Bough... Source: Rick Munarriz

Sep 29, 2025 @ 5:35 PM 10 Health Care Stocks With Whale Alerts In Today's... Source: Benzinga Staff Writer

Aug 5, 2025 @ 10:00 AM Lipid Nanoparticles Market Industry Trends, Key Gr... Source: Researchandmarkets.Com

Jul 18, 2025 @ 8:56 AM RNA Therapeutics and RNA Vaccines Market Industry ... Source: Researchandmarkets.Com

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-2.4	$-1.05	$-2.4
Diluted EPS	$-2.4	$-1.05	$-2.4
Revenue	$82.03M	$7.2M	$82.03M
Gross Profit
Net Income / Loss	$-65.78M	$-29.08M	$-65.78M
Operating Income / Loss	$-76.26M	$-31.31M	$-76.26M
Cost of Revenue
Net Cash Flow	$-61.12M	$-4.45M	$-61.12M
PE Ratio

Splits
Nov 16, 2017	1:7